Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amgen (NQ: AMGN)
199.00 USD  +0.11 (+0.05%)
Streaming Delayed Price  /  Updated: 9:45 AM EST, Jan 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 91,081
Open 198.38
Bid (Size) 198.94 (2)
Ask (Size) 199.08 (1)
Prev. Close 198.89
Today's Range 197.98 - 199.24
52wk Range 163.31 - 210.19
Shares Outstanding 661,706,000
Dividend Yield 2.65%
Performance
YTD
+3.70%
+3.70%
1 Month
+4.69%
+4.69%
3 Month
-1.86%
-1.86%
6 Month
+3.21%
+3.21%
1 Year
+7.25%
+7.25%
Top News
More News
Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY™ (romosozumab)
Potential New Treatment Option for the Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture Read More
from PR Newswire
UPDATE 2-Amgen's postmenopausal osteoporosis drug wins FDA panel backing
An advisory panel to the U.S. Food and Drug Administration said on Wednesday that benefits of Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture outweighed its risks... Read More
category companyNews
from Reuters: Company News
More News
Read More
UPDATE 1-Amgen's postmenopausal osteoporosis drug wins FDA panel backing
category companyNews
from Reuters: Company News
Amgen's postmenopausal osteoporosis drug wins FDA panel backing
category companyNews
from Reuters: Company News
Notable ETF Outflow Detected - IBB, AMGN, ILMN, REGN
category ETFs
from ETF Channel
The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen
category Benzinga , XBI , STIM , and 15 more.
from Benzinga
DowDuPont Moves Up In Market Cap Rank, Passing Amgen
category Stocks
from Market News Video
U.S. lawmaker launches investigation into pharma drug pricing
category companyNews
from Reuters: Company News
Here's How The Government Shutdown Will Affect These Medical Stocks
from Investor's Business Daily
House Democrats launch drug pricing probe into a dozen major health-care companies
category Johnson & Johnson , Biotechnology , Sanofi SA , and 16 more.
from CNBC.com News
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
category IBB , Biotech , FPRX , and 19 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.